EMPOWERING MYELOMA ADVOCACY ACROSS EUROPE


LinkedIn facebook twitter youtube
News archive

 

Myeloma Patients Europe (MPE) held a webinar Minimal Residual Disease (MRD) in myeloma and related diseases given by Paula van Hennik, Committee for Medicinal Products for Human Use (CHMP) member at the European Medicine Agency (EMA).

This webinar is part of the AGM 2020 webinars series planned to replace the Masterclass included in the MPE Annual General Meeting (AGM) 2020, which was cancelled due to the outbreak of the COVID-19 infection.

Find below the recording of this webinar or watch it on our YouTube Channel:

 

 

 







Recent news

» COVID-19 vaccines for myeloma patients: what you need to know

» Horizon2020 CARAMBA Myeloma Pipeline information sheet now available in five languages

Leave a Reply

Your email address will not be published. Required fields are marked *

I accept the Privacy Policy * for Click to select the duration you give consent until.